TissueGen® Inc., Dallas, Texas, has developed a breakthrough drug-delivery system that consists of polymers that can be integrated into implantable fabrics and medical devices. The polymer technology includes fiber extrusion at room temperature, which preserves the biological activity of therapeutic agents that might be deteriorated under high temperature extrusion techniques. Biomedical Structures LLC, Warwick, R.I., a developer of biomedical textiles, will integrate the polymers into drug-releasing medical devices, such as small diameter vascular grafts and stents, sutures and other implantable technologies. The unique polymer process can be used for many drugs and other therapeutics, such as enzymes and growth factors, and can be custom engineered for specific applications. Drugs are incorporated into the fabrics using commercially available polymer components, including polylactic acid and polydioxanone.
Absorbable polymers deliver medications
Advanced Textiles, Industry News | August 1, 2013 | By: ATA
You might also like...
2024 Techtextil and Texprocess Innovation Award winners announced
FabricLink Network announces development of The Textile Gateway
DITF and VRETENA win Cellulose Fiber Innovation of the Year 2024 Award
New DHS textile enforcement plan cracks down on illicit trade
NCTO praises DHS textile, apparel enforcement plan
Fashion for Good welcomes 10 companies to 2024 Innovation Program